English
简体中文
Total: £ 56.28
Published Date: 2025-09-11 | Pages: 91 | Tables: 97 | Pharma & Healthcare
The global Antiserum market size was US$ 1509 million in 2024 and is forecast to a readjusted size of US$ 2407 million by 2031 with a CAGR of 6.8% during the forecast period 2025-2031.
Antiserum, a type of blood serum that contains specific antibodies against an antigen (foreign agent), such as an infective organism or poisonous substance. Antibodies in antiserum work by detecting and subsequently neutralizing antigens. Antiserums are produced in animals, most commonly horses, sheep, oxen, and rabbits, and in humans, in response to infection, intoxication, or vaccination. Animal and human antiserums can be used in other individuals to confer immunity to a specific disease or to treat bites or stings of venomous animals. Antiserum widely used in diagnostic virology laboratories. The most common use of antiserum in humans is as antitoxin or antivenom to treat envenomation.
The Antiserum market belongs to the pharmaceutical industry, and its development is closely related to economic development and people's quality of life. Antiserum is used in the treatment of snake venom, rabies, tetanus, etc. and bacterial detection. The market potential is huge. Policy support and emphasis on food and water safety are the main factors promoting market development.
Product safety risks, high industry barriers, high safety requirements, and stricter market regulation are the main factors hindering market development.
In terms of regional development, at present, the sources of market supply are mainly concentrated in North America. With the technological development and progress of Asian countries, in the future, we can focus on the development trend of Asian regions.
In terms of market competition, due to the higher technical barriers and stricter regulation of biopharmaceuticals, the market competition is relatively mild.
The major global companies of Antiserum include CSL，Merck，BTG，Pfizer，CNBG and etc. The top five vendors held 59% of the market.
In the future, with the continuous development of the market and the increase of new entrants, relevant companies need to fully promote the clinical research and preclinical research of new products, and at the same time continue to research and explore, and strive to achieve technological innovation and breakthroughs in existing products and improve product quality compete with safe, effective, economical and suitable product differentiation, and avoid being eliminated by the continuously developing market.
The global Antiserum market is strategically segmented by company, region (country), by Type, and by Application. This report empowers stakeholders to capitalize on emerging opportunities, optimize product strategies, and outperform competitors through data-driven insights on revenue and forecasts across regions, by Type, and by Application for 2020-2031.
Market Segmentation
By Company:
CSL
Merck
BTG
Pfizer
CNBG
Bharat Serums and Vaccines
Haffkine Bio-Pharmaceutical
Serum Biotech
Bio-Rad
BD
Vins Bioproducts
FUJIFILM Wako Pure Chemical Corporation
SSI Diagnostica
GD Animal Health
By Type: (Dominant Segment vs High-Margin Innovation)
Antitoxin Serum
Antibacterial Serum
Antiviral Serum
Others
By Application: (Core Demand Driver vs Emerging Opportunity)
Clinical
Laboratory
By Region
Macro-Regional Analysis: Market Size & Growth Forecasts
- North America
- Europe
- Asia-Pacific
- South America
- Middle East & Africa
Micro-Local Market Deep Dive: Strategic Insights
- Competitive Landscape: Player dominance vs. disruptors (e.g., CSL in Europe)
- Emerging Product Trends: Antitoxin Serum adoption vs. Antibacterial Serum premiumization
- Demand-Side Dynamics: Clinical growth in China vs. Laboratory potential in North America
- Localized Consumer Needs: Regulatory hurdles in EU vs. price sensitivity in India
Focus Markets:
North America
Europe
China
Japan
India
(Additional regions can be customized based on client needs.)
Chapter Outline
Chapter 1: Report scope, executive summary, and market evolution scenarios (short/mid/long term).
Chapter 2: Quantitative analysis of Antiserum market size and growth potential at global, regional, and country levels.
Chapter 3: Competitive benchmarking of manufacturers (revenue, market share, M&A, R&D focus).
Chapter 4: Type-based segmentation analysis – Uncovering blue ocean markets (e.g., Antibacterial Serum in China).
Chapter 5: Application-based segmentation analysis – High-growth downstream opportunities (e.g., Laboratory in India).
Chapter 6: Regional revenue breakdown by company, type, application and customer.
Chapter 7: Key manufacturer profiles – Financials, product portfolios, and strategic developments.
Chapter 8: Market dynamics – Drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 9: Actionable conclusions and strategic recommendations.
Why This Report?
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Antiserum value chain, addressing:
- Market entry risks/opportunities by region
- Product mix optimization based on local practices
- Competitor tactics in fragmented vs. consolidated markets
Research Methodology
The research methodology employed has been subjected by numerous procedures in order to guarantee the quality and accuracy of the data contained within the reports. The analysts are employed full-time and received more than six months training to satisfy the standard of our company. Our methodology can be divided into five stages:
★Stage 1 SECONDARY RESEARCH
The research team first collaborates with magazines, trade associations and administrative departments in the research field. The information provided by our internal documentation service is helpful for our further research. Our team has a wealth of experience and knowledge, and can effectively extract accurate information from existing resources.
★Stage 2 PRIMARY RESEARCH:INTERVIEWS WITH TRADE SOURCES
After the first stage, the research team conducts a large number of face-to-face or telephone interviews with representative companies working in the research field. Analysts are trying to have an opportunity to talk to leading companies and small companies in the field. Upstream suppliers, manufacturers, distributors, importers, installers, wholesalers and consumers were included in the interview. The data collected during the interview were then carefully examined and compared with the secondary study.
★Stage 3 ANALYSIS OF THE GATHERED DATA
The analysis team examines and synthesizes the data collected in the first two stages. In order to validate the data, a second round of interviews can be conducted.
★Stage 4 QUANTITATIVE DATA
The quantitative data such as market estimates, production and capacity of manufacturer, market forecasts and investment feasibility is provided by our company. The data is based on the estimates obtained during stage 3.
★Stage 5 QUALITY CONTROL
Before publishing, each report undergoes a rigorous review and editing process, which is done by the experience management team to ensure the reliability of the published data. Every analyst on the research team receives support and continuous training as part of our internal quality process.
1 Report Overview
1.1 Study Scope
1.2 Market by Type
1.2.1 Global Market Size Growth by Type: 2020 VS 2024 VS 2031
1.2.2 Antitoxin Serum
1.2.3 Antibacterial Serum
1.2.4 Antiviral Serum
1.2.5 Others
1.3 Market by Application
1.3.1 Global Market Share by Application: 2020 VS 2024 VS 2031
1.3.2 Clinical
1.3.3 Laboratory
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Antiserum Market Perspective (2020-2031)
2.2 Global Market Size by Region: 2020 VS 2024 VS 2031
2.3 Global Antiserum Revenue Market Share by Region (2020-2025)
2.4 Global Antiserum Revenue Forecast by Region (2026-2031)
2.5 Major Region and Emerging Market Analysis
2.5.1 North America Antiserum Market Size and Prospective (2020-2031)
2.5.2 Europe Antiserum Market Size and Prospective (2020-2031)
2.5.3 China Antiserum Market Size and Prospective (2020-2031)
2.5.4 Japan Antiserum Market Size and Prospective (2020-2031)
2.5.5 India Antiserum Market Size and Prospective (2020-2031)
3 Breakdown Data by Type
3.1 Global Antiserum Historic Market Size by Type (2020-2025)
3.2 Global Antiserum Forecasted Market Size by Type (2026-2031)
3.3 Different Types Antiserum Representative Players
4 Breakdown Data by Application
4.1 Global Antiserum Historic Market Size by Application (2020-2025)
4.2 Global Antiserum Forecasted Market Size by Application (2026-2031)
4.3 New Sources of Growth in Antiserum Application
5 Competition Landscape by Players
5.1 Global Top Players by Revenue
5.1.1 Global Top Antiserum Players by Revenue (2020-2025)
5.1.2 Global Antiserum Revenue Market Share by Players (2020-2025)
5.2 Global Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
5.3 Players Covered: Ranking by Antiserum Revenue
5.4 Global Antiserum Market Concentration Analysis
5.4.1 Global Antiserum Market Concentration Ratio (CR5 and HHI)
5.4.2 Global Top 10 and Top 5 Companies by Antiserum Revenue in 2024
5.5 Global Key Players of Antiserum Head office and Area Served
5.6 Global Key Players of Antiserum, Product and Application
5.7 Global Key Players of Antiserum, Date of Enter into This Industry
5.8 Mergers & Acquisitions, Expansion Plans
6 Region Analysis
6.1 North America Market: Players, Segments and Downstream
6.1.1 North America Antiserum Revenue by Company (2020-2025)
6.1.2 North America Market Size by Type
6.1.2.1 North America Antiserum Market Size by Type (2020-2025)
6.1.2.2 North America Antiserum Market Share by Type (2020-2025)
6.1.3 North America Market Size by Application
6.1.3.1 North America Antiserum Market Size by Application (2020-2025)
6.1.3.2 North America Antiserum Market Share by Application (2020-2025)
6.1.4 North America Market Trend and Opportunities
6.2 Europe Market: Players, Segments and Downstream
6.2.1 Europe Antiserum Revenue by Company (2020-2025)
6.2.2 Europe Market Size by Type
6.2.2.1 Europe Antiserum Market Size by Type (2020-2025)
6.2.2.2 Europe Antiserum Market Share by Type (2020-2025)
6.2.3 Europe Market Size by Application
6.2.3.1 Europe Antiserum Market Size by Application (2020-2025)
6.2.3.2 Europe Antiserum Market Share by Application (2020-2025)
6.2.4 Europe Market Trend and Opportunities
6.3 China Market: Players, Segments and Downstream
6.3.1 China Antiserum Revenue by Company (2020-2025)
6.3.2 China Market Size by Type
6.3.2.1 China Antiserum Market Size by Type (2020-2025)
6.3.2.2 China Antiserum Market Share by Type (2020-2025)
6.3.3 China Market Size by Application
6.3.3.1 China Antiserum Market Size by Application (2020-2025)
6.3.3.2 China Antiserum Market Share by Application (2020-2025)
6.3.4 China Market Trend and Opportunities
6.4 Japan Market: Players, Segments and Downstream
6.4.1 Japan Antiserum Revenue by Company (2020-2025)
6.4.2 Japan Market Size by Type
6.4.2.1 Japan Antiserum Market Size by Type (2020-2025)
6.4.2.2 Japan Antiserum Market Share by Type (2020-2025)
6.4.3 Japan Market Size by Application
6.4.3.1 Japan Antiserum Market Size by Application (2020-2025)
6.4.3.2 Japan Antiserum Market Share by Application (2020-2025)
6.4.4 Japan Market Trend and Opportunities
6.5 India Market: Players, Segments and Downstream
6.5.1 India Antiserum Revenue by Company (2020-2025)
6.5.2 India Market Size by Type
6.5.2.1 India Antiserum Market Size by Type (2020-2025)
6.5.2.2 India Antiserum Market Share by Type (2020-2025)
6.5.3 India Market Size by Application
6.5.3.1 India Antiserum Market Size by Application (2020-2025)
6.5.3.2 India Antiserum Market Share by Application (2020-2025)
6.5.4 India Market Trend and Opportunities
7 Key Players Profiles
7.1 CSL
7.1.1 CSL Company Details
7.1.2 CSL Business Overview
7.1.3 CSL Antiserum Introduction
7.1.4 CSL Revenue in Antiserum Business (2020-2025)
7.1.5 CSL Recent Development
7.2 Merck
7.2.1 Merck Company Details
7.2.2 Merck Business Overview
7.2.3 Merck Antiserum Introduction
7.2.4 Merck Revenue in Antiserum Business (2020-2025)
7.2.5 Merck Recent Development
7.3 BTG
7.3.1 BTG Company Details
7.3.2 BTG Business Overview
7.3.3 BTG Antiserum Introduction
7.3.4 BTG Revenue in Antiserum Business (2020-2025)
7.3.5 BTG Recent Development
7.4 Pfizer
7.4.1 Pfizer Company Details
7.4.2 Pfizer Business Overview
7.4.3 Pfizer Antiserum Introduction
7.4.4 Pfizer Revenue in Antiserum Business (2020-2025)
7.4.5 Pfizer Recent Development
7.5 CNBG
7.5.1 CNBG Company Details
7.5.2 CNBG Business Overview
7.5.3 CNBG Antiserum Introduction
7.5.4 CNBG Revenue in Antiserum Business (2020-2025)
7.5.5 CNBG Recent Development
7.6 Bharat Serums and Vaccines
7.6.1 Bharat Serums and Vaccines Company Details
7.6.2 Bharat Serums and Vaccines Business Overview
7.6.3 Bharat Serums and Vaccines Antiserum Introduction
7.6.4 Bharat Serums and Vaccines Revenue in Antiserum Business (2020-2025)
7.6.5 Bharat Serums and Vaccines Recent Development
7.7 Haffkine Bio-Pharmaceutical
7.7.1 Haffkine Bio-Pharmaceutical Company Details
7.7.2 Haffkine Bio-Pharmaceutical Business Overview
7.7.3 Haffkine Bio-Pharmaceutical Antiserum Introduction
7.7.4 Haffkine Bio-Pharmaceutical Revenue in Antiserum Business (2020-2025)
7.7.5 Haffkine Bio-Pharmaceutical Recent Development
7.8 Serum Biotech
7.8.1 Serum Biotech Company Details
7.8.2 Serum Biotech Business Overview
7.8.3 Serum Biotech Antiserum Introduction
7.8.4 Serum Biotech Revenue in Antiserum Business (2020-2025)
7.8.5 Serum Biotech Recent Development
7.9 Bio-Rad
7.9.1 Bio-Rad Company Details
7.9.2 Bio-Rad Business Overview
7.9.3 Bio-Rad Antiserum Introduction
7.9.4 Bio-Rad Revenue in Antiserum Business (2020-2025)
7.9.5 Bio-Rad Recent Development
7.10 BD
7.10.1 BD Company Details
7.10.2 BD Business Overview
7.10.3 BD Antiserum Introduction
7.10.4 BD Revenue in Antiserum Business (2020-2025)
7.10.5 BD Recent Development
7.11 Vins Bioproducts
7.11.1 Vins Bioproducts Company Details
7.11.2 Vins Bioproducts Business Overview
7.11.3 Vins Bioproducts Antiserum Introduction
7.11.4 Vins Bioproducts Revenue in Antiserum Business (2020-2025)
7.11.5 Vins Bioproducts Recent Development
7.12 FUJIFILM Wako Pure Chemical Corporation
7.12.1 FUJIFILM Wako Pure Chemical Corporation Company Details
7.12.2 FUJIFILM Wako Pure Chemical Corporation Business Overview
7.12.3 FUJIFILM Wako Pure Chemical Corporation Antiserum Introduction
7.12.4 FUJIFILM Wako Pure Chemical Corporation Revenue in Antiserum Business (2020-2025)
7.12.5 FUJIFILM Wako Pure Chemical Corporation Recent Development
7.13 SSI Diagnostica
7.13.1 SSI Diagnostica Company Details
7.13.2 SSI Diagnostica Business Overview
7.13.3 SSI Diagnostica Antiserum Introduction
7.13.4 SSI Diagnostica Revenue in Antiserum Business (2020-2025)
7.13.5 SSI Diagnostica Recent Development
7.14 GD Animal Health
7.14.1 GD Animal Health Company Details
7.14.2 GD Animal Health Business Overview
7.14.3 GD Animal Health Antiserum Introduction
7.14.4 GD Animal Health Revenue in Antiserum Business (2020-2025)
7.14.5 GD Animal Health Recent Development
8 Antiserum Market Dynamics
8.1 Antiserum Industry Trends
8.2 Antiserum Market Drivers
8.3 Antiserum Market Challenges
8.4 Antiserum Market Restraints
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.1.1 Research Programs/Design
10.1.1.2 Market Size Estimation
10.1.1.3 Market Breakdown and Data Triangulation
10.1.2 Data Source
10.1.2.1 Secondary Sources
10.1.2.2 Primary Sources
10.2 Author Details
10.3 Disclaimer
List of Tables
Table 1. Global Antiserum Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Global Antiserum Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 3. Global Market Antiserum Market Size (US$ Million) by Region:2020 VS 2024 VS 2031
Table 4. Global Antiserum Revenue (US$ Million) Market Share by Region (2020-2025)
Table 5. Global Antiserum Revenue Share by Region (2020-2025)
Table 6. Global Antiserum Revenue (US$ Million) Forecast by Region (2026-2031)
Table 7. Global Antiserum Revenue Share Forecast by Region (2026-2031)
Table 8. Global Antiserum Market Size by Type (2020-2025) & (US$ Million)
Table 9. Global Antiserum Revenue Market Share by Type (2020-2025)
Table 10. Global Antiserum Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 11. Global Antiserum Revenue Market Share by Type (2026-2031)
Table 12. Representative Players of Each Type
Table 13. Global Antiserum Market Size by Application (2020-2025) & (US$ Million)
Table 14. Global Antiserum Revenue Market Share by Application (2020-2025)
Table 15. Global Antiserum Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 16. Global Antiserum Revenue Market Share by Application (2026-2031)
Table 17. New Sources of Growth in Antiserum Application
Table 18. Global Antiserum Revenue by Players (2020-2025) & (US$ Million)
Table 19. Global Antiserum Market Share by Players (2020-2025)
Table 20. Global Top Antiserum Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Antiserum as of 2024)
Table 21. Ranking of Global Top Antiserum Companies by Revenue (US$ Million) in 2024
Table 22. Global 5 Largest Players Market Share by Antiserum Revenue (CR5 and HHI) & (2020-2025)
Table 23. Global Key Players of Antiserum, Headquarters and Area Served
Table 24. Global Key Players of Antiserum, Product and Application
Table 25. Global Key Players of Antiserum, Date of Enter into This Industry
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. North America Antiserum Revenue by Company (2020-2025) & (US$ Million)
Table 28. North America Antiserum Revenue Market Share by Company (2020-2025)
Table 29. North America Antiserum Market Size by Type (2020-2025) & (US$ Million)
Table 30. North America Antiserum Market Size by Application (2020-2025) & (US$ Million)
Table 31. Europe Antiserum Revenue by Company (2020-2025) & (US$ Million)
Table 32. Europe Antiserum Revenue Market Share by Company (2020-2025)
Table 33. Europe Antiserum Market Size by Type (2020-2025) & (US$ Million)
Table 34. Europe Antiserum Market Size by Application (2020-2025) & (US$ Million)
Table 35. China Antiserum Revenue by Company (2020-2025) & (US$ Million)
Table 36. China Antiserum Revenue Market Share by Company (2020-2025)
Table 37. China Antiserum Market Size by Type (2020-2025) & (US$ Million)
Table 38. China Antiserum Market Size by Application (2020-2025) & (US$ Million)
Table 39. Japan Antiserum Revenue by Company (2020-2025) & (US$ Million)
Table 40. Japan Antiserum Revenue Market Share by Company (2020-2025)
Table 41. Japan Antiserum Market Size by Type (2020-2025) & (US$ Million)
Table 42. Japan Antiserum Market Size by Application (2020-2025) & (US$ Million)
Table 43. India Antiserum Revenue by Company (2020-2025) & (US$ Million)
Table 44. India Antiserum Revenue Market Share by Company (2020-2025)
Table 45. India Antiserum Market Size by Type (2020-2025) & (US$ Million)
Table 46. India Antiserum Market Size by Application (2020-2025) & (US$ Million)
Table 47. CSL Company Details
Table 48. CSL Business Overview
Table 49. CSL Antiserum Product
Table 50. CSL Revenue in Antiserum Business (2020-2025) & (US$ Million)
Table 51. CSL Recent Development
Table 52. Merck Company Details
Table 53. Merck Business Overview
Table 54. Merck Antiserum Product
Table 55. Merck Revenue in Antiserum Business (2020-2025) & (US$ Million)
Table 56. Merck Recent Development
Table 57. BTG Company Details
Table 58. BTG Business Overview
Table 59. BTG Antiserum Product
Table 60. BTG Revenue in Antiserum Business (2020-2025) & (US$ Million)
Table 61. BTG Recent Development
Table 62. Pfizer Company Details
Table 63. Pfizer Business Overview
Table 64. Pfizer Antiserum Product
Table 65. Pfizer Revenue in Antiserum Business (2020-2025) & (US$ Million)
Table 66. Pfizer Recent Development
Table 67. CNBG Company Details
Table 68. CNBG Business Overview
Table 69. CNBG Antiserum Product
Table 70. CNBG Revenue in Antiserum Business (2020-2025) & (US$ Million)
Table 71. CNBG Recent Development
Table 72. Bharat Serums and Vaccines Company Details
Table 73. Bharat Serums and Vaccines Business Overview
Table 74. Bharat Serums and Vaccines Antiserum Product
Table 75. Bharat Serums and Vaccines Revenue in Antiserum Business (2020-2025) & (US$ Million)
Table 76. Bharat Serums and Vaccines Recent Development
Table 77. Haffkine Bio-Pharmaceutical Company Details
Table 78. Haffkine Bio-Pharmaceutical Business Overview
Table 79. Haffkine Bio-Pharmaceutical Antiserum Product
Table 80. Haffkine Bio-Pharmaceutical Revenue in Antiserum Business (2020-2025) & (US$ Million)
Table 81. Haffkine Bio-Pharmaceutical Recent Development
Table 82. Serum Biotech Company Details
Table 83. Serum Biotech Business Overview
Table 84. Serum Biotech Antiserum Product
Table 85. Serum Biotech Revenue in Antiserum Business (2020-2025) & (US$ Million)
Table 86. Serum Biotech Recent Development
Table 87. Bio-Rad Company Details
Table 88. Bio-Rad Business Overview
Table 89. Bio-Rad Antiserum Product
Table 90. Bio-Rad Revenue in Antiserum Business (2020-2025) & (US$ Million)
Table 91. Bio-Rad Recent Development
Table 92. BD Company Details
Table 93. BD Business Overview
Table 94. BD Antiserum Product
Table 95. BD Revenue in Antiserum Business (2020-2025) & (US$ Million)
Table 96. BD Recent Development
Table 97. Vins Bioproducts Company Details
Table 98. Vins Bioproducts Business Overview
Table 99. Vins Bioproducts Antiserum Product
Table 100. Vins Bioproducts Revenue in Antiserum Business (2020-2025) & (US$ Million)
Table 101. Vins Bioproducts Recent Development
Table 102. FUJIFILM Wako Pure Chemical Corporation Company Details
Table 103. FUJIFILM Wako Pure Chemical Corporation Business Overview
Table 104. FUJIFILM Wako Pure Chemical Corporation Antiserum Product
Table 105. FUJIFILM Wako Pure Chemical Corporation Revenue in Antiserum Business (2020-2025) & (US$ Million)
Table 106. FUJIFILM Wako Pure Chemical Corporation Recent Development
Table 107. SSI Diagnostica Company Details
Table 108. SSI Diagnostica Business Overview
Table 109. SSI Diagnostica Antiserum Product
Table 110. SSI Diagnostica Revenue in Antiserum Business (2020-2025) & (US$ Million)
Table 111. SSI Diagnostica Recent Development
Table 112. GD Animal Health Company Details
Table 113. GD Animal Health Business Overview
Table 114. GD Animal Health Antiserum Product
Table 115. GD Animal Health Revenue in Antiserum Business (2020-2025) & (US$ Million)
Table 116. GD Animal Health Recent Development
Table 117. Antiserum Market Trends
Table 118. Antiserum Market Drivers
Table 119. Antiserum Market Challenges
Table 120. Antiserum Market Restraints
Table 121. Research Programs/Design for This Report
Table 122. Key Data Information from Secondary Sources
Table 123. Key Data Information from Primary Sources
List of Figures
Figure 1. Antiserum Product Picture
Figure 2. Global Antiserum Market Share by Type: 2024 VS 2031
Figure 3. Antitoxin Serum Features
Figure 4. Antibacterial Serum Features
Figure 5. Antiviral Serum Features
Figure 6. Others Features
Figure 7. Global Antiserum Market Share by Application: 2024 VS 2031
Figure 8. Clinical
Figure 9. Laboratory
Figure 10. Antiserum Report Years Considered
Figure 11. Global Antiserum Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 12. Global Antiserum Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 13. Global Antiserum Revenue Market Share by Region: 2020 VS 2024
Figure 14. North America Antiserum Revenue (US$ Million) Growth Rate (2020-2031)
Figure 15. Europe Antiserum Revenue (US$ Million) Growth Rate (2020-2031)
Figure 16. China Antiserum Revenue (US$ Million) Growth Rate (2020-2031)
Figure 17. Japan Antiserum Revenue (US$ Million) Growth Rate (2020-2031)
Figure 18. India Antiserum Revenue (US$ Million) Growth Rate (2020-2031)
Figure 19. Global Antiserum Market Share by Players in 2024
Figure 20. Global Top Antiserum Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Antiserum as of 2024)
Figure 21. The Top 10 and 5 Players Market Share by Antiserum Revenue in 2024
Figure 22. North America Antiserum Market Share by Type (2020-2025)
Figure 23. North America Antiserum Market Share by Application (2020-2025)
Figure 24. Europe Antiserum Market Share by Type (2020-2025)
Figure 25. Europe Antiserum Market Share by Application (2020-2025)
Figure 26. China Antiserum Market Share by Type (2020-2025)
Figure 27. China Antiserum Market Share by Application (2020-2025)
Figure 28. Japan Antiserum Market Share by Type (2020-2025)
Figure 29. Japan Antiserum Market Share by Application (2020-2025)
Figure 30. India Antiserum Market Share by Type (2020-2025)
Figure 31. India Antiserum Market Share by Application (2020-2025)
Figure 32. CSL Revenue Growth Rate in Antiserum Business (2020-2025)
Figure 33. Merck Revenue Growth Rate in Antiserum Business (2020-2025)
Figure 34. BTG Revenue Growth Rate in Antiserum Business (2020-2025)
Figure 35. Pfizer Revenue Growth Rate in Antiserum Business (2020-2025)
Figure 36. CNBG Revenue Growth Rate in Antiserum Business (2020-2025)
Figure 37. Bharat Serums and Vaccines Revenue Growth Rate in Antiserum Business (2020-2025)
Figure 38. Haffkine Bio-Pharmaceutical Revenue Growth Rate in Antiserum Business (2020-2025)
Figure 39. Serum Biotech Revenue Growth Rate in Antiserum Business (2020-2025)
Figure 40. Bio-Rad Revenue Growth Rate in Antiserum Business (2020-2025)
Figure 41. BD Revenue Growth Rate in Antiserum Business (2020-2025)
Figure 42. Vins Bioproducts Revenue Growth Rate in Antiserum Business (2020-2025)
Figure 43. FUJIFILM Wako Pure Chemical Corporation Revenue Growth Rate in Antiserum Business (2020-2025)
Figure 44. SSI Diagnostica Revenue Growth Rate in Antiserum Business (2020-2025)
Figure 45. GD Animal Health Revenue Growth Rate in Antiserum Business (2020-2025)
Figure 46. Bottom-up and Top-down Approaches for This Report
Figure 47. Data Triangulation
Figure 48. Key Executives Interviewed
